未登录

D

David A. Middleton

lancaster university

H指数:29

被引数:2,537

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Illuminating High-Affinity ATP Binding to the Sodium-Potassium Pump Using Solid-State NMR Spectroscopy

利用固态核磁共振波谱法揭示钠钾泵的高亲和力ATP结合。

Molecules 2025, Vol. 30, Page 3609

IF4.6

2025-09-030

OA

Complete removal of toxic herbicides and structural insight by a heteromolecular aggregate

通过异分子聚集体的除草剂完全去除及其结构洞察

Journal of Hazardous Materials

IF11.3

2025-07-110

OA

Conformational Analysis of Uniformly 13C-Labeled Peptides by Rotationally Selected 13Cα-13CH3 Double-Quantum Solid-State NMR

IF4.6

2025-02-060

OAAI

Encapsulation of toxic liquid molecules and adsorption of water pollutants by a versatile pre-organized single crystalline coating material

通过一种多功能的预组织单晶涂层材料对有毒液体分子进行封装以及对水污染物的吸附

INORGANIC CHEMISTRY FRONTIERS

IF6.4

2025-01-010

PRE

NMR studies of amyloid interactions

Progress in Nuclear Magnetic Resonance Spectroscopy

IF8.2

2024-11-010

OAAI

Characterization of Olive Oil Phenolic Extracts and Their Effects on the Aggregation of the Alzheimer's Amyloid-β Peptide and Tau

IF4.3

2024-07-172

OAAI

Vascular smooth muscle cell senescence accelerates medin aggregation via small extracellular vesicle secretion and extracellular matrix reorganization

IF7.1

2022-11-2513

OAAI

Raman Spectroscopy with 2D Perturbation Correlation Moving Windows for the Characterization of Heparin-Amyloid Interactions

ANALYTICAL CHEMISTRY

IF6.7

2020-09-166

OAAI

Circular Dichroism Spectroscopy Identifies the β-Adrenoceptor Agonist Salbutamol As a Direct Inhibitor of Tau Filament Formation in Vitro

ACS CHEMICAL NEUROSCIENCE

IF3.9

2020-06-1017

PREAI

Drug orientations within statin-loaded lipoprotein nanoparticles by 19F solid-state NMR

CHEMICAL COMMUNICATIONS

IF4.2

2019-01-015

OAAI

Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2018-08-0119

OAAI

Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-β Fibrils

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2016-07-0548

OAAI

Novel stereoselective bufadienolides reveal new insights into the requirements for Na+, K+-ATPase inhibition by cardiotonic steroids

SCIENTIFIC REPORTS

IF3.9

2016-07-0526

OAAI

Comparisons with Amyloid-β Reveal an Aspartate Residue That Stabilizes Fibrils of the Aortic Amyloid Peptide Medin

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2015-03-0115

OAAI

Site-Specific Identification of an Aß Fibril-Heparin Interaction Site by Using Solid-State NMR Spectroscopy

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2012-11-1427

OA

Amyloid-Derived Peptide Forms Self-Assembled Mono layers on Gold Nanoparticle with a Curvature-Dependent β-Sheet Structure

IF16

2012-01-2093

PREAI

The Conformation of ATP within the Na,K-ATPase Nucleotide Site: A Statistically Constrained Analysis of REDOR Solid-State NMR Data

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2011-06-1022

PREAI

Inhibitors of protein aggregation and toxicity

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2009-07-2260

PREAI

Structural Insights into the Polymorphism of Amyloid-Like Fibrils Formed by Region 20-29 of Amylin Revealed by Solid-State NMR and X-ray Fiber Diffraction

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2008-10-21184

PREAI

Design of an N-methylated peptide inhibitor of α-synuclein aggregation guided by solid-state NMR

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2008-05-30101

OAAI